The world is facing a growing crisis of antimicrobial resistance (AMR), and a new study reveals a particularly alarming trend: the rapid rise in AMR among children. This issue is not just a concern for the future; it's a pressing problem that demands immediate attention and action. The study, published in JAMA Paediatrics, analyzed bacterial data from 106,581 children aged 0-18 over an 18-year period, revealing a concerning pattern of increasing resistance across all 82 countries covered by the data.
What makes this finding even more alarming is the focus on Gram-negative bacteria, which are responsible for severe infections like sepsis and pneumonia. The study highlights the growing resistance to antibiotics in these bacteria, particularly in the 'Watch' and 'Reserve' categories of the Access, Watch, and Reserve (AWaRe) system, designed by the World Health Organization (WHO) to manage antibiotic use. The 'Watch' category includes antibiotics that are commonly used for treating common infections, while the 'Reserve' category is reserved for last-resort treatments.
The study's findings are a wake-up call, suggesting that the overuse of antibiotics in these categories is leading to increased resistance, which could render these antibiotics ineffective in treating severe childhood infections. This is especially concerning in regions with limited alternative treatment options, where the consequences of antibiotic resistance could be devastating.
The study also emphasizes the need for improved surveillance and access to effective antibiotics for children. In low-income countries, addressing unregulated antibiotic use and poor sanitation is crucial. These countries require better access to diagnostic techniques and first-line antibiotics to combat the growing AMR crisis. In high-income countries, the focus should be on reducing antibiotic overuse in farming, veterinary, primary care, and hospital settings, while infection control remains a priority.
Furthermore, the study highlights the importance of child-friendly antibiotic formulations, clearer dosing guidance, and funding for trials on safely reducing antibiotic use. Consumers play a role too, as they can contribute by discussing the risks of overprescribing antibiotics with their GPs.
A separate study, published in Lancet Public Health, adds to the urgency by showing that many regions are using more antibiotics than expected, with a particular reliance on the 'Watch' class of antibiotics. This study developed a method to calculate optimal antibiotic use levels for 186 countries based on disease burden, resistance, and local context. The findings revealed that most countries used more antibiotics than necessary in 2019, with almost every nation showing excessive use of 'Watch' antibiotics, which contribute significantly to antibiotic resistance.
The implications of this research are far-reaching. As Professor Mark Morgan, Chair of the RACGP Expert Committee – Quality Care, points out, resistant microbes could alter the balance of harm and benefit for various medical procedures, including cancer treatments and joint replacements. Common antibiotics may no longer be as effective, and this could have a significant impact on public health and healthcare systems.
In Australia, while antibiotic use has increased in recent years, it remains lower than in 2015. However, reducing low-value antibiotic use is crucial to addressing AMR. The Therapeutic Guidelines provide broad guidance on antibiotic choice, but there are still gaps in Australian data, particularly regarding privately dispensed antibiotics and the appropriateness of antibiotic use. Better data collection and analysis are essential to optimizing antibiotic use and combating the growing AMR crisis.
In conclusion, the rise in AMR among children is a critical global health issue that requires urgent action. The study's findings underscore the need for improved surveillance, access to effective antibiotics, and a comprehensive approach to reducing antibiotic overuse. By addressing these challenges, we can work towards preserving the efficacy of antibiotics and ensuring a healthier future for our children and generations to come.
